206 related articles for article (PubMed ID: 28820750)
1. The New Realization About Cribriform Prostate Cancer.
Iczkowski KA; Paner GP; Van der Kwast T
Adv Anat Pathol; 2018 Jan; 25(1):31-37. PubMed ID: 28820750
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
3. A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.
Hesterberg AB; Rios BL; Wolf EM; Tubbs C; Wong HY; Schaffer KR; Lotan TL; Giannico GA; Gordetsky JB; Hurley PJ
J Pathol Clin Res; 2021 May; 7(3):271-286. PubMed ID: 33600062
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.
Minardi D; Mazzucchelli R; Scarpelli M; Massari F; Ciccarese C; Lopez-Beltran A; Cheng L; Montironi R
Future Oncol; 2016 Jun; 12(12):1431-3. PubMed ID: 27189718
[No Abstract] [Full Text] [Related]
5. Proliferation index of different Gleason pattern 4 histomorphologies and associated pattern 3 adenocarcinoma of the prostate.
Fu L; Hwang M; Adeniran AJ; Humphrey PA
Hum Pathol; 2017 Dec; 70():1-5. PubMed ID: 28666926
[TBL] [Abstract][Full Text] [Related]
6. Does prostatic ductal adenocarcinoma exist?
Bock BJ; Bostwick DG
Am J Surg Pathol; 1999 Jul; 23(7):781-5. PubMed ID: 10403300
[TBL] [Abstract][Full Text] [Related]
7. Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria.
Egevad L; Delahunt B; Iczkowski KA; van der Kwast T; van Leenders GJLH; Leite KRM; Pan CC; Samaratunga H; Tsuzuki T; Mulliqi N; Ji X; Olsson H; Valkonen M; Ruusuvuori P; Eklund M; Kartasalo K
Histopathology; 2023 May; 82(6):837-845. PubMed ID: 36645163
[TBL] [Abstract][Full Text] [Related]
8. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
Ronen S; Abbott DW; Kravtsov O; Abdelkader A; Xu Y; Banerjee A; Iczkowski KA
Hum Pathol; 2017 Jul; 65():85-91. PubMed ID: 28504208
[TBL] [Abstract][Full Text] [Related]
9. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
10. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
11. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.
Iczkowski KA; van Leenders GJLH; Tarima S; Wu R; Van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Ro JY; Samaratunga H; Delahunt B; Srigley J; Varma M; Tsuzuki T; Egevad L
Ann Diagn Pathol; 2021 Jun; 52():151733. PubMed ID: 33780691
[TBL] [Abstract][Full Text] [Related]
12. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
13. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
Au S; Villamil CF; Alaghehbandan R; Wang G
Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
[TBL] [Abstract][Full Text] [Related]
14. Cribriform adenocarcinoma of the prostate.
McNeal JE; Reese JH; Redwine EA; Freiha FS; Stamey TA
Cancer; 1986 Oct; 58(8):1714-9. PubMed ID: 3756794
[TBL] [Abstract][Full Text] [Related]
15. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
16. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology.
Latour M; Amin MB; Billis A; Egevad L; Grignon DJ; Humphrey PA; Reuter VE; Sakr WA; Srigley JR; Wheeler TM; Yang XJ; Epstein JI
Am J Surg Pathol; 2008 Oct; 32(10):1532-9. PubMed ID: 18724248
[TBL] [Abstract][Full Text] [Related]
17. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
18. The association of the cribriform pattern with outcome for prostatic adenocarcinomas.
Kir G; Sarbay BC; Gümüş E; Topal CS
Pathol Res Pract; 2014 Oct; 210(10):640-4. PubMed ID: 25042388
[TBL] [Abstract][Full Text] [Related]
19. Grading of prostatic adenocarcinoma: current state and prognostic implications.
Gordetsky J; Epstein J
Diagn Pathol; 2016 Mar; 11():25. PubMed ID: 26956509
[TBL] [Abstract][Full Text] [Related]
20. Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.
Dong F; Yang P; Wang C; Wu S; Xiao Y; McDougal WS; Young RH; Wu CL
Am J Surg Pathol; 2013 Dec; 37(12):1855-61. PubMed ID: 24145642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
